Related references
Note: Only part of the references are listed.Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery
Ruediger Klingeler et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2008)
Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?
Maha Saad et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Frank Alexis et al.
MOLECULAR PHARMACEUTICS (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Active targeting of brain tumors using nanocarriers
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Temperature-sensitive poly(N-(2-hydroxypropyl)methacrylamide mono/dilactate)-coated liposomes for triggered contents release
Lauri Paasonen et al.
BIOCONJUGATE CHEMISTRY (2007)
Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the n-type calcium channel antagonists ω-conotoxin GVIA and ω-conotoxin MVIIA
Maciej Gasior et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery
Lilian E. van Vlerken et al.
PHARMACEUTICAL RESEARCH (2007)
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
Abhijit A. Date et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Nanostructured lipid carriers (NLC) in cosmetic dermal products
R. H. Mueller et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain
T. Lopez et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2007)
The determination of dielectric constants of mixtures used in the treatment of epilepsy and the encapsulation of phenytoin in a titania matrix
T. Lopez et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2007)
Intraventricular administration of gabapentin in the rat increases flurothyl seizure threshold
Joseph Oommen et al.
NEUROSCIENCE LETTERS (2007)
Absence seizures are reduced by the enhancement of GABA-ergic inhibition in the hippocampus in WAG/Rij rats
Elena A. Tolmacheva et al.
NEUROSCIENCE LETTERS (2007)
Seizure-promoting effect of blood-brain barrier disruption
Nicola Marchi et al.
EPILEPSIA (2007)
Incorporation of water-soluble drugs in PLGA microspheres
Fuminori Ito et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2007)
Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy
E. A. van Vliet et al.
BRAIN (2007)
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetarn and carbamazepine by human and mouse P-glycoprotein
Steffen Baltes et al.
NEUROPHARMACOLOGY (2007)
EEG-fMRI in children with pharmacoresistant focal epilepsy
Xavier De Tiege et al.
EPILEPSIA (2007)
Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats
Mehmet Yildirim et al.
BRAIN RESEARCH (2007)
EEG wavelet analyses of the striatum-substantia nigra pars reticulata-superior colliculus circuitry:: Audiogenic seizures and anticonvulsant drug administration in Wistar audiogenic rats (War strain)
Franco Rossetti et al.
EPILEPSY RESEARCH (2006)
The multidrug transporter hypothesis of drug resistance in epilepsy:: Proof-of-principle in a rat model of temporal lobe epilepsy
Claudia Brandt et al.
NEUROBIOLOGY OF DISEASE (2006)
Expression of multidrug resistance type 1 gene (MDR1) P-glycoprotein in intractable epilepsy with different aetiologies: a double-labelling and electron microscopy study
D. Chengyun et al.
NEUROLOGICAL SCIENCES (2006)
Effect of intracerebroventricular continuous infusion of valproic acid versus single i.p. and i.c.v. injections in the amygdala kindling epilepsy model
Alfonso Serralta et al.
EPILEPSY RESEARCH (2006)
Nanotechnology: Intelligent design to treat complex disease
Patrick Couvreur et al.
PHARMACEUTICAL RESEARCH (2006)
Fabrication and characterization of microfluidic probes for convection enhanced drug delivery
KB Neeves et al.
JOURNAL OF CONTROLLED RELEASE (2006)
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space
RG Thorne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lack of interactions between breast cancer resistance protein (BCRP/ABCG2) and selected antiepileptic agents
L Cerveny et al.
EPILEPSIA (2006)
Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies
SM Sisodiya et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
DE Owens et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Astrocyte-endothelial interactions at the blood-brain barrier
NJ Abbott et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Intraocular sustained drug delivery using implantable polymeric devices
T Yasukawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Polyethylene glycol (PEG) modified 99mTc-HMPAO-liposome for improving blood circulation and biodistribution:: The effect of the extent of PEGylation
CM Lee et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Local distribution and toxicity of prolonged hippocampal infusion of muscimol
JD Heiss et al.
JOURNAL OF NEUROSURGERY (2005)
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26
Y Aktas et al.
BIOCONJUGATE CHEMISTRY (2005)
Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats
EA van Vliet et al.
EPILEPSIA (2005)
Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system
MY Chen et al.
JOURNAL OF NEUROSURGERY (2005)
Cell cavities increase tortuosity in brain extracellular space
A Tao et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Targeting of daunomycin using biotinylated immunoliposomes:: Pharmacokinetics, tissue distribution and in vitro pharmacological effects
A Schnyder et al.
JOURNAL OF DRUG TARGETING (2005)
Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus
P Iannetti et al.
EPILEPSIA (2005)
Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating
JA MacKay et al.
BRAIN RESEARCH (2005)
Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy
E Aronica et al.
EPILEPSIA (2004)
Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model
A Lazarowski et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2004)
XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: I.: Design, synthesis, enzymatic conversion to gabapentin, and transport by intestinal solute transporters
KC Cundy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: II.: Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
KC Cundy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study
W Boogerd et al.
EUROPEAN JOURNAL OF CANCER (2004)
Focally injected adenosine prevents seizures in the rat
DJ Anschel et al.
EXPERIMENTAL NEUROLOGY (2004)
Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy
MA Summers et al.
ANNALS OF PHARMACOTHERAPY (2004)
The blood-brain barrier choline transporter as a brain drug delivery vector
DD Allen et al.
LIFE SCIENCES (2003)
Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity
H Potschka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors
E Aronica et al.
NEUROSCIENCE (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Effect of transient hippocampal inhibition on amygdaloid kindled seizures and arnygdaloid kindling rate
J Mirnajafi-Zadeh et al.
BRAIN RESEARCH (2002)
Design and characterization of liposomes containing long-chain N-AcylPEs for brain delivery:: Penetration of liposomes incorporating GM1 into the rat brain
M Mora et al.
PHARMACEUTICAL RESEARCH (2002)
Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent:: Pharmacokinetics and distribution of doxorubicin in brain and other tissues
GP Zara et al.
JOURNAL OF DRUG TARGETING (2002)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
The intracerebral administration of phenytoin using controlled-release polymers reduces experimental seizures in rats
RJ Tamargo et al.
EPILEPSY RESEARCH (2002)
Building drug delivery into tissue engineering
WM Saltzman et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Potential new methods for antiepileptic drug delivery
RS Fisher et al.
CNS DRUGS (2002)
Nanoparticle technology for drug delivery across the blood-brain barrier
PR Lockman et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2002)
Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy
SM Dombrowski et al.
EPILEPSIA (2001)
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Z Panagi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (Human non-acquired immunodeficiency syndrome) and survival
DF Kraemer et al.
NEUROSURGERY (2001)
Multidrug-resistance protein 1 in focal cortical dysplasia
SM Sisodiya et al.
LANCET (2001)
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
M Bialer et al.
EPILEPSY RESEARCH (2001)
Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in vitro-in vivo study
M Dutt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2001)
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
RA Jain
BIOMATERIALS (2000)
Current status of pH-sensitive liposomes in drug delivery
DC Drummond et al.
PROGRESS IN LIPID RESEARCH (2000)
Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles
Duane T. Birnbaum et al.
JOURNAL OF NANOPARTICLE RESEARCH (2000)
Permeable endothelium and the interstitial space of brain
MW Brightman et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans
T Siegal et al.
JOURNAL OF NEUROSURGERY (2000)
Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system
A Cerletti et al.
JOURNAL OF DRUG TARGETING (2000)
Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system
A Friese et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)